Cytochrome P450 Enzymes and Drug Metabolism—Basic Concepts and Methods of Assessment
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 19 (3) , 309-323
- https://doi.org/10.1023/a:1006993631057
Abstract
1. The cytochrome P450 enzyme family is one of the major drug metabolizing systems in man. 2. Factors such as age, gender, race, environment, and drug treatment may have considerable influence on the activity of these enzymes. 3. There are now well-established in vitro techniques for assessing the role of specific cytochrome P450 enzymes in the metabolism of drugs, as well as the inhibitory or inducing effects of drugs on enzyme activity. In vitro data have been utilized to predict clinical outcomes (i.e., pharmacokinetic interactions), with close correlations between in vitro and in vivo data. 4. This information can be of considerable practical assistance to clinicians, to help with rational prescribing or to prevent or minimize the potential for drug interactions.Keywords
This publication has 73 references indexed in Scilit:
- Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation*Clinical Pharmacology & Therapeutics, 1996
- Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.1996
- Cytochromes P450 Expression SystemsAnnual Review of Pharmacology and Toxicology, 1995
- Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2* activitiesClinical Pharmacology & Therapeutics, 1992
- Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicityThe FASEB Journal, 1992
- Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplificationThe Lancet, 1990
- Interindividual and interethnic differences in the demethylation and glucuronidation of codeine.British Journal of Clinical Pharmacology, 1989
- Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intakeEuropean Journal of Clinical Investigation, 1989
- Pathway-selective sex differences in the metabolic clearance of propranolol in human subjectsClinical Pharmacology & Therapeutics, 1989
- SLOW HYDROXYLATION OF NORTRIPTYLINE AND CONCOMITANT POOR DEBRISOQUINE HYDROXYLATION: CLINICAL IMPLICATIONSThe Lancet, 1981